Associate Director, Competitive Intelligence

Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan with key operations in the U.S. (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada, Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the U.S., Canada, and Europe, and a diverse pipeline of early- to late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn.

Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. The company’s diverse portfolio includes several marketed products and a robust pipeline of early- to late-stage assets. Building on Sumitomo Pharma’s 125-year legacy of innovation, SMPA leverages proprietary in-house technology platforms and advanced analytics capabilities to accelerate discovery, development, and help bring novel therapies to patients sooner. SMPA is a Sumitomo Pharma company. [For more information, visit Sumitomo-pharma.com]

Job Overview

The Associate Director, Competitive Intelligence will seek out, collect, curate, synthesize and deliver key insights and implications on the competitive environment, including marketed products and pipeline compounds.  The Associate Director should identify and effectively communicate regarding overarching corporate strategies, clinical development programs, and commercial capabilities of key competitors, and overall market trends. The Associate Director will prioritize CI activities based on strategic business questions and relevant cross-functional stakeholders, including in Commercial, Clinical Development, Medical Affairs, Regulatory, Sales leadership and Finance/IR functions.

Job Duties and Responsibilities

•    Proactively gathering, summarizing and reporting competitive information in the oncology, women’s health, and overactive bladder therapeutic markets.
•    Providing context and objective analysis of competitive information to inform business decision-making.
•    Leading core CI initiatives, congress coverage, workshops, monitoring/news.
•    Creating and updating content on competitor products, launch timelines and product profiles.
•    Mapping and assessing competitive dynamics in key indications and/or therapeutic areas.
•    Effectively communicating key competitive information and potential implications to cross-functional teams and leadership throughout the organization.
•    Providing scientific conference coverage and analysis of clinical data, commercial presence, key themes from a disease area perspective.
•    Supporting stakeholders in the development of function-specific deliverables including forecasts, market assessments, and brand plans.
•    Partnering with third party agencies to support CI projects.
•    Following pre-defined standards to ensure legal and ethical approaches to CI, protecting business interests and confidentiality.
•    Attend key congresses (i.e. ASH, ASCO, AUA, etc.) and provide updates on key presentations to the congress attendees.
•    Support ad-hoc CI initiatives for pipeline and on-market products.
•    Collaborate with Commercial Analytics to develop business deliverables.

Key Core Competencies

•    Ability to see big picture opportunities and translate into actionable plans.
•    Strong communications skills including communicating with senior leadership.
•    Experience with the pharmaceutical commercial environment and business needs.
•    Familiarity with pharmaceutical data sources (e.g., IQVIA, SHA, MMIT).
•    Proven success in managing external vendors.
•    Strong team and collaborative capabilities.
•    Experience managing multiple cross-functional stakeholders.
•    Flexibility and capacity to learn new disease areas when required, and to support multiple competing stakeholder priorities and requests.
•    Ability to effectively simplify an